Related Content
Feature | Antiplatelet and Anticoagulation Therapies| Nicole Fornell, Pharm D
The standard-of-care for dual antiplatelet therapy (DAPT) for more than a decade has been clopidogrel (Plavix) plus ...
August 28, 2012
February 23, 2012 — AstraZeneca announced that the American College of Chest Physicians (ACCP) has updated its ...
February 23, 2012November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
November 09, 2011
July 21, 2011 – The U.S. Food and Drug Administration (FDA) today approved AstraZeneca’s blood-thinning drug ticagrelor ...
July 21, 2011June 29, 2011 – The experimental antiplatelet drug ticagrelor prevented significantly more cardiovascular complications ...
June 29, 2011December 17, 2010 - The U.S. Food and Drug Administration (FDA) has requested additional analyses of the trial data in ...
December 17, 2010
October 25, 2010 - A post-hoc-analysis from JUPITER, published in the European Heart Journal, shows rosuvastatin ...
October 25, 2010September 15, 2010 – The U.S. Food and Drug Administration (FDA) has extended the time to complete its review of the new ...
September 15, 2010July 29, 2010 – A new, highly anticipated antiplatelet drug was recommended yesterday for final approval by the U.S ...
July 29, 2010July 13, 2010 – AstraZeneca recently announced that the U.S. District Court has found that the substance patent ...
July 13, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now